BA, Earlham College (1997) ; MS, University of California, Santa Barbara (2003); MPH, Saw Swee Hock School of Public Health, National University of Singapore (2010); PhD, Saw Swee Hock School of Public Health, National University of Singapore (2015); Research fellow/Senior technical specialist, Malaria Elimination Initiative, University of California, San Francisco (2014-2018)
Area(s) of Specialization:
Malaria; Infectious Disease Epidemiology; Vector-borne disease; Global Health; Epidemiological Study Design
I am an infectious disease epidemiologist with substantive focuses in malaria (especially Plasmodium vivax), other vector-borne diseases, and disease surveillance, all coupled with the design and implementation of field surveys and interventional trials.
This work is motivated by the reality that health interventions generally target broad population groups, due to a lack of detailed data on subpopulations at highest risk. This "broad brush" strategy often leads to inefficient and ineffective programs. My research strives to ensure health interventions utilize best-available epidemiological evidence to maximize the impact of inherently limited health budgets.
My work has involved field work in diverse global settings, including studies in Timor-Leste (East Timor), Cambodia, Vietnam, Lao PDR (Laos), and Kenya, and has also included elements of qualitative research and community health to support epidemiological outcomes.
Current and on-going studies include: 1) trialing a novel vector-control intervention for malaria elimination (Vietnam); 2) trialing strategies for targeted malaria surveillance in marginalized populations (Laos, Vietnam and Cambodia); and 3) studies to understand the epidemiology of tick-borne disease (Western Massachusetts).
I am also the Deputy Director of the CDC-funded New England Center of Excellence in Vector-borne Disease. This regional consortium (based at UMass) compromises a wide range of academic and public health partners from across New England. Further information: https://www.newvec.org/
AA Lover, E Dantzer, B Hongvanthong, K Chindavongsa, S Welty, T Reza, N Khim, D Menard, A Bennett. Prevalence and risk factors for asymptomatic malaria and genotyping of glucose 6-phosphate (G6PD) deficiencies in a vivax-predominant setting, Lao PDR: implications for sub-national elimination goals. Malaria Journal (2018); 17(1); 218.
AA Lover, JK Baird, R Gosling, RN Price. Malaria elimination: time to target all species. American Journal of Tropical Medicine and Hygiene (2018); 99(1), 17–23.
MN Balm, AA Lover, S Salmon, PA Tambyah, DA Fisher. Progression from new methicillin-resistant Staphylococcus aureus colonisation to infection: an observational study in a hospital cohort. BMC Infectious Diseases (2013); 13, 491.
AA Lover, RJ Coker. Quantifying effect of geographic location on epidemiology of Plasmodium vivax malaria. Emerging Infectious Diseases (2013); 19(7), 1058-1065
AA Lover, BA Sutton, AJ Asy, A Wilder-Smith. An exploratory study of treated-bed nets in Timor-Leste: patterns of intended and alternative usage. Malaria Journal (2011); 10(1), 199.